Tenascin mediates human glioma cell migration and modulates cell migration on fibronectin

Journal of Cell Science

Volumn 109, Issue 3, 1996, Pages 643-652

  Deryugina, Elena I ^a   Bourdon, Mario A ^a  

^a La Jolla Institute for Experimental Medicine   (United States)

Author keywords

Cell adhesion; Cell adhesion molecule; Cell migration; Extracellular matrix protein; Fibronectin; Integrin; Tenascin

Indexed keywords

BLOCKING ANTIBODY; FIBRONECTIN; INTEGRIN; TENASCIN;

ARTICLE; CELL CONTACT; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL STRUCTURE; CONTROLLED STUDY; GLIOMA CELL; PRIORITY JOURNAL; TUMOR CELL; TUMOR SPHEROID;

BASE SEQUENCE; CELL MOVEMENT; FIBRONECTINS; GLIOMA; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PICHIA; TENASCIN; TUMOR CELLS, CULTURED;

EID: 0030007495     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Aufderheide, E., Chiquet-Ehrismann, R. and Ekbiom, P. (1987) Epithelial-mesenchymal interactions in the developing kidney lead to expression of tenascin in the mesenchyme J. Cell Biol 105, 599-608.
2. Aufderheide, E. and Ekblom, P. (1988). Tenascin during gut development: appearance in the mesenchyme, shift in molecular forms, and dependence on epithelial-mesenchymal interactions. (Published erratum appears in J. Cell Biol. (1989) 108(3): following 1175). J Cell Biol. 107, 2341-2349.
3. Bourdon, M. A., Wikstrand, C. J., Furthmayr, H., Matthews, T. J. and Bigner, D. D. (1983). Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody. Cancer Res. 43, 2796-805.
4. Bourdon, M. A. and Ruoslahti, E. (1989). Tenascin mediates cell attachment through an RGD-dependent receptor. J. Cell Biol. 108, 1149-1155.
5. Chiquet-Ehrismann, R., Mackie, E. J., Pearson, C. A. and Sakakura, T. (1986). Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 47, 131-139.
6. Chiquet-Ehrismann, R., Kalla, P., Pearson, C. A., Beck, K. and Chiquet, M. (1988). Tenascin interferes with fibronectin action. Cell 53, 383-390.
7. Chuong, C. M., Crossin, K. L. and Edelman, G. M. (1987). Sequential expression and differential function of multiple adhesion molecules during the formation of cerebellar cortical layers. J. Cell Biol. 104, 331-342.
8. Crossin, K. L., Hoffman, S., Grumet, M., Thiery, J. P. and Edelman, G. M. (1986). Site-restricted expression of cytotactin during development of the chicken embryo. J. Cell Biol. 102, 1917-1930.
9. Erickson, H. P. and Bourdon, M. A. (1989) Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors. Annu. Rev. Cell Biol. 5, 71-92.
10. Grumet, M., Hoffman, S., Crossin, K. L. and Edelman, G. M. (1985). Cytotactin, an extracellular matrix protein of neural and non-neural tissues that mediates glia-neuron interaction. Proc. Nat. Acad. Sci. USA 82, 8075-8079.
11. 2+. J. Cell Biol. 117, 1109-1117.
12. Guarino, M., Reale, D. and Micoli, G. (1993). The extracellular matrix in sarcomatoid carcinomas of the breast. Virchows. Arch. A Pathol. Anat. Histopathol. 423, 131-136.
13. Halfter, W., Chiquet-Ehrismann, R. and Tucker, R. P. (1989). The effect of tenascin and embryonic basal lamina on the behavior and morphology of neural crest cells in vitro. Dev. Biol. 132, 14-25.
14. Higuchi, M., Ohnishi, T., Arita, N., Hiraga, S. and Hayakawa, T. (1993). Expression of tenascin in human gliomas: its relation to histological malignancy, tumor dedifferentiation and angiogenesis. Acta Neuropathol. (Berl.) 85, 481-487.
15. Husmann, K., Faissner, A. and Schachner, M. (1992). Tenascin promotes cerebellar granule cell migration and neurite outgrowth by different domains in the fibronectin type III repeats. J. Cell Biol. 116, 1475-1486.
16. Hynes, R. O. (1992). Integrins: versatility, modulation, and signaling in cell adhesion Cell 69, 11-25.
17. Joshi, P., Chung, C. Y., Aukhil, I. and Erickson, H. P. (1993). Endothelial cells adhere to the RGD domain and the fibrinogen-like terminal knob of tenascin J. Cell Sci. 106, 389-400.
18. Kilian, P. L., Kaffka, K. L., Biondi, D. A., Lipman, J. M., Benjamin, W. R., Feldman, D. and Campen, C. A. (1991). Antiproliferative effect of interleukin-1 on human ovarian carcinoma cell line (NIH:OVCAR-3). Cancer Res. 51, 1823-1828.
19. 1 is upregulated in fibroblasts and highly aggressive melanoma cells in three-dimensional collagen lattices and mediates the reorganization of collagen I fibrils. J Cell Biol. 115, 1427-1436.
20. 5-directed cell motility but not adhesion on vitronectin. J. Cell Biol. 127, 859-866.
21. Lochter, A., Vaughan, L., Kaplony, A., Prochiantz, A., Schachner, M. and Faissner, A. (1991). J1/tenascin in substratum-bound and soluble form displays contrary effects on neurite outgrowth J. Cell Biol. 113, 1159-1171
22. Luomanen, M., and Virtanen, I. (1993). Distribution of tenascin in healing incision, excision and laser wounds. J. Oral. Pathol. Med. 22, 41-45.
23. Mackie, E. J., Chiquet-Ehrismann, R., Pearson, C. A., Inaguma, Y., Taya, K., Kawarada, Y. and Sakakura, T. (1987) Tenascin is a stromal marker for epithelial malignancy in the mammary gland. Proc. Nat. Acad. Sci. USA 84, 4621-4625.
24. Mackie, E. J., Halfter, W. and Liverani, D. (1988). Induction of tenascin in healing wounds. J. Cell Biol. 107, 2757-2767.
25. Prieto, A. L., Edelman, G. M. and Crossin, K. (1993). Multiple integrins mediate cell attachment to cytotactin/tenascin. Proc. Nat. Acad. Sci. USA 21, 10154-10158.
26. Ruoslahti, E., Hayman, E. G., Pierschbacher, M. and Engvall, E. (1982). Fibronectin: Purification, immunochemical properties, and biolgical activities. Meth. Enzymol. 82, 803-831.
27. Sage, E. H. and Bornstein, P. (1991). Extracellular proteins that modulate cell-matrix interactions. SPARC, tenascin, and thrombospondin. J. Biol. Chem. 266, 14831-14834.
28. Sakai, T., Kawakatsu, H., Hirota, N., Yokoyama, T., Sakakura, T. and Saito, M. (1993). Specific expression of tenascin in human colonic neoplasms. Br. J. Cancer 67, 1058-1064.
29. Sano, Y., Hoshino, T., Bjerkvig, R. and Deen, D. F. (1983) The relative resistance of non-cycling cells in 9L multicellular spheroids to spirohydantoin mustard. Eur. J. Cancer Clin. Oncol. 19, 1451-1456.
30. 1 (VLA-2) mediates reorganization and contraction of collagen matrices by human cells. Cell 67, 403-410.
31. Sriramarao, P. and Bourdon, M. A. (1993). A novel tenascin type III repeat is part of a complex of tenascin mRNA alternative splices. Nucl. Acids Res. 21, 163-168.
32. Sriramarao, P. and Bourdon, M. A. (1995). Melanoma cell invasive and metastatic potential cerrelates with endothelial cell reorganization and tenascin expression. Endothelium (in press).
33. 3 integrins. J Cell Sci 105, 1001-1012.
34. Steindler, D. A., Cooper, N. G., Faissner, A. and Schachner, M. (1989). Boundaries defined by adhesion molecules during development of the cerebral cortex: the J1/tenascin glycoprotein in the mouse somatosensory cortical barrel field. Dev. Biol. 131, 243-260.
35. Thesleff, I., Mackie, E., Vainio, S. and Chiquet-Ehrismann, R. (1987). Changes in the distribution of tenascin during tooth development Development 101, 289-296.
36. Yamada, E. M., Kennedy, D. W., Yamada, S. S., Gralnick, H., Chen, W-T. and Akiyama, S. K. (1990). Monoclonal antibody and synthetic peptide inhibitors of human tumor cell migration. Cancer Res. 50, 4485-4496
37. 1 mediates cell attachment to a non-RGD site in the third fibronectin type III repeat of tenascin. J. Biol Chem. 269, 26691-26696.
38. Zagzag, D., Friedlander, D. R., Miller, D. C., Dosik, J., Cangiarella, J., Kostianovsky, M., Cohen, H., Grumet, M. and Greco, M. A. (1995). Tenascin expression in astrocytomas correlates with angiogenesis. Cancer Res. 55, 907-914.